Takeda Pharmaceutical
TAK
$15.96
Share price
-0.06%
Change (1 day)
14.90%
Change (1 year)
Categories
Earnings for Takeda Pharmaceutical (TAK)
Earnings in 2023 (TTM): $4.27 B
According to Takeda Pharmaceutical's latest financial reports the company's current earnings (TTM) are $4.27 B. In 2022 the company made an earning of $3.53 B a decrease over its 2021 earnings that were of $6.46 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Takeda Pharmaceutical from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $4.27 B | 20.79% |
| 2022 | $3.53 B | -45.27% |
| 2021 | $6.46 B | 103.46% |
| 2020 | $3.17 B | 860.47% |
| 2019 | $0.33 B | -80.59% |
| 2018 | $1.70 B | -23.86% |
| 2017 | $2.23 B | 21.77% |
| 2016 | $1.83 B | -253.22% |
| 2015 | -$1.2 B | -159.7% |
| 2014 | $2.00 B | 19.62% |
| 2013 | $1.67 B | -3.19% |
| 2012 | $1.73 B | -57.11% |
| 2011 | $4.04 B | -10.11% |
| 2010 | $4.50 B | -4.2% |
| 2009 | $4.69 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.83 B | 481.11% | 🇺🇸 USA |
 Novartis NVS | $9.16 B | 114.53% | 🇨🇭 Switzerland |
 Pfizer PFE | $24.22 B | 466.70% | 🇺🇸 USA |
 Amgen AMGN | $9.19 B | 115.16% | 🇺🇸 USA |
 Sanofi SNY | $9.96 B | 133.08% | 🇫🇷 France |
 Merck MRK | $6.38 B | 49.44% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.96 B | 86.47% | 🇬🇧 UK |
 Seagen
SGEN | -$0.76 B | -117.60% | 🇺🇸 USA |
 Dr. Reddy's RDY | $0.78 B | -81.63% | 🇮🇳 India |